1. Rashid RA, Zgair A, Al-Ani RM. Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study. American Journal of Otolaryngology. 2021 Sep 1;42(5):103033.
2. Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial. American Journal of Otolaryngology. 2021 Mar 1;42(2):102884.
3. Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. Jama. 2020 Jun 23;323(24):2512-4.
4. Li X, Lui F. Anosmia. In: Stat Pearls. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.
5. Han AY, Mukdad L, Long JL, Lopez IA. Anosmia in COVID-19: mechanisms and significance. Chemical senses. 2020 Jul;45(6):423-8.
6. Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. American journal of otolaryngology. 2020 Jun 2:102581.
7. Hura N, Xie DX, Choby GW, Schlosser RJ, Orlov CP, et al. Treatment of post‐viral olfactory dysfunction: an evidence‐based review with recommendations. InInternational Forum of Allergy & Rhinology 2020 Sep (Vol. 10, No. 9, pp. 1065-1086).
8. Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: A systematic review. Wellcome open research. 2020;5.
9. Miwa T, Ikeda K, Ishibashi T, Kobayashi M, Kondo K, et al. Clinical practice guidelines for the management of olfactory dysfunction—secondary publication. Auris Nasus Larynx. 2019 Oct 1;46(5):653-62.
10. Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. European Archives of Oto-Rhino-Laryngology. 2020 Jul;277(7):1885-97.
11. Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial. American Journal of Otolaryngology. 2021 Mar 1;42(2):102884.
12. Le Bon SD, Konopnicki D, Pisarski N, Prunier L, Lechien JR, et al. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. European Archives of Oto-Rhino-Laryngology. 2021 Jan 9:1-5.
13. Singh CV, Jain S, Parveen S. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients. American journal of otolaryngology. 2021 May 1;42(3):102892.
14. Huart C, Philpott CM, Altundag A, Fjaeldstad AW, Frasnelli J, et al. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view. InInternational forum of allergy & rhinology 2021 Mar 16.
15. Saussez, S.; Vaira, L.A.; Chiesa-Estomba, C.M.; Bon, S.-DL.; Horoi, M.; et al. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens 2021, 10, 698.
16. Ikeda K, Sakurada T, Suzaki Y, Takasaka T. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology. 1995 Sep;33(3):162-165.